ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years
Linxun Liu
Matched on ORCID iD 0000-0003-1998-5746; OpenAlex author ID A5062864008. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 2 papers
Papers 8
- HIF-1α modulates pancreatic cancer ECM proteins via the TGF-β1/Smad signaling pathway introduction. Last author DOI 10.3389/fonc.2025.1564655↗
- Correction: HIF-1α modulates pancreatic cancer ECM proteins via the TGF-β1/Smad signaling pathway introduction. Last author DOI 10.3389/fonc.2025.1648986↗
- Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer via HSP90 and PI3K/Akt/mTOR pathways Last author DOI 10.21203/rs.3.rs-2952795/v1↗
- Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α. First author DOI 10.3389/fphar.2023.1138265↗
- Novel green synthesis and characterization of a chemotherapeutic supplement by silver nanoparticles containing Berberis thunbergii leaf for the treatment of hu… Last author DOI 10.1002/bab.2160↗
- Advances in research on the relationship between thymoquinone and pancreatic cancer. First author DOI 10.3389/fonc.2022.1092020↗
- Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Co-author DOI 10.1007/s00210-021-02126-x↗
- S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Co-author DOI 10.1007/s00210-019-01617-2↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhanxue Zhao · 5 shared papers, 2022–2025 · strength 1.46
- Paper HIF-1α modulates pancreatic cancer ECM proteins via the TGF-β1/Smad signaling pathway introduction. DOI 10.3389/fonc.2025.1564655↗
- Paper Correction: HIF-1α modulates pancreatic cancer ECM proteins via the TGF-β1/Smad signaling pathway introduction. DOI 10.3389/fonc.2025.1648986↗
- Paper Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer via HSP90 and PI3K/Akt/mTOR pathways DOI 10.21203/rs.3.rs-2952795/v1↗
- Houle Guo · 2 shared papers, 2025 · strength 0.85
- Jinyu Yang · 2 shared papers, 2023 · strength 0.41
- Paper Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer via HSP90 and PI3K/Akt/mTOR pathways DOI 10.21203/rs.3.rs-2952795/v1↗
- Paper Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible fact… DOI 10.3389/fphar.2023.1138265↗
- Lei Qin · 2 shared papers, 2019–2021 · strength 0.27
- Paper Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreati… DOI 10.1007/s00210-021-02126-x↗
- Paper S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK… DOI 10.1007/s00210-019-01617-2↗
- Genhai Shen · 2 shared papers, 2019–2021 · strength 0.27
- Paper Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreati… DOI 10.1007/s00210-021-02126-x↗
- Paper S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK… DOI 10.1007/s00210-019-01617-2↗
- Jinyu Yang · 1 shared paper, 2022 · strength 0.20
- Juan Guo · 1 shared paper, 2022 · strength 0.16
- Yan Liu · 1 shared paper, 2021 · strength 0.16
- Yan Liu · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.